Segment and Geographical Information (Tables)

3 Months Ended

Dec. 31, 2017

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

The tables below present segment revenue, operating (loss) income and depreciation and amortization, as follows:

	Three Months Ended
	December 31,
(Dollars in thousands)	2017			2016
Revenue:
Medical Device	$	12,774		$	13,757
In Vitro Diagnostics		4,239			4,004
Total revenue	$	17,013		$	17,761
Operating (loss) income:
Medical Device	$	(389	)	$	3,719
In Vitro Diagnostics		1,670			1,456
Total segment operating income		1,281			5,175
Corporate		(1,914	)		(1,907	)
Total operating (loss) income	$	(633	)	$	3,268
Depreciation and amortization:
Medical Device	$	1,272		$	1,004
In Vitro Diagnostics		90			103
Corporate		158			175
Total depreciation and amortization	$	1,520		$	1,282